Basic Information
Basic information for LINC00343-285-18aa
Peptide Name LINC00343-285-18aa
Genome Position chr13:105707583-105707629,105707714-105707720[+]
Species Human
Peptide Sequence MQKELELPQGASKTLSLH
Peptide Length 18
Unique No (LINC00343-203-18aa,LINC00343-217-18aa,LINC00343-220-18aa,LINC00343-222-18aa,LINC00343-226-18aa,LINC00343-233-18aa,LINC00343-242-18aa,LINC00343-259-18aa,LINC00343-268-18aa,LINC00343-271-18aa,LINC00343-276-18aa,LINC00343-277-18aa,LINC00343-280-18aa,LINC00343-283-18aa,LINC00343-298-18aa,LINC00343-305-18aa,LINC00343-330-18aa)
Grand Average of Hydropathicity -0.5778
Relative Molecular Mass 2316.62
Experimental Evidences no
lncRNA ID/Name ENSG00000226620;LINC00343
Transcript ID/Name ENST00000667217;LINC00343-285
Transcript Length 1389
Coding Ability 0.5961
DNA Sequence Corresponding to Peptide ATGCAAAAGGAATTAGAACTGCCACAAGGTGCAAGCAAAACCTTGAGTCTCCAT
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :